Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Power-Stem Biomedical Research is a Taiwan-based biotechnology company specializing in regenerative medicine and advanced cell-based therapies. The company focuses on the development and clinical application of mesenchymal stem cells (MSCs) and natural killer (NK) cells for treating cancer and degenerative diseases. Power-Stem operates state-of-the-art GXP-compliant facilities for cell banking and the production of clinical-grade biologics. Their business model integrates proprietary cell expansion technologies with clinical partnerships to provide personalized medical solutions. The company is actively involved in clinical trials for indications such as solid tumors and osteoarthritis within the Taiwanese regulatory landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Power-Stem Biomedical Research.